美股
Lead report
Novartis and Antares Strike $1.9 Billion Deal: A New Breakthrough in Oncology Drug Development
Novartis and Antares Pharmaceuticals announce a collaboration to develop cancer drugs, with a potential value of $1.9 billion. This article analyzes the deal details, market reactions, and implications for US stock investors, covering oncology industry trends and investment strategies.
